APA (7th ed.) Citation

Rogers, C. J., Harman, R. J., Bunnell, B. A., Schreiber, M. A., Xiang, C., Wang, F., . . . Minev, B. R. (2020). Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients. Journal of translational medicine, 18(1), 203-19. https://doi.org/10.1186/s12967-020-02380-2

Chicago Style (17th ed.) Citation

Rogers, Christopher J., Robert J. Harman, Bruce A. Bunnell, Martin A. Schreiber, Charlie Xiang, Fu-Sheng Wang, Antonio F. Santidrian, and Boris R. Minev. "Rationale for the Clinical Use of Adipose-derived Mesenchymal Stem Cells for COVID-19 Patients." Journal of Translational Medicine 18, no. 1 (2020): 203-19. https://doi.org/10.1186/s12967-020-02380-2.

MLA (9th ed.) Citation

Rogers, Christopher J., et al. "Rationale for the Clinical Use of Adipose-derived Mesenchymal Stem Cells for COVID-19 Patients." Journal of Translational Medicine, vol. 18, no. 1, 2020, pp. 203-19, https://doi.org/10.1186/s12967-020-02380-2.